COMP <GO>
CNC vs GH // 10Y YIELD & FRED MACRO BETA
Centene Corporation (NYSE) VS. Guardant Health Inc. (NASDAQ) • 15-METRIC TALLY: CNC 5
— GH 6
▲ 10Y YIELD & FRED MACRO BETA LEADER: CNC
LAST: $68.45 (-0.25%) • MKT CAP: $33.89B
macro-sensitivity
0.94
LAST: $178.80 (-3.51%) • MKT CAP: $23.99B
macro-sensitivity
0.87
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNC VS. GH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNC | GH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 8.10% | 64.50% | -56.40 | GH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.00% | -17.40% | -13.60 | GH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.72% | -0.94% | +13.66 | CNC | /fcf-yield <GO> |
| Operating Margin | -4.40% | -44.50% | +40.10 | CNC | /operating-margins <GO> |
| Net Profit Margin | -3.80% | -42.40% | +38.60 | CNC | /net-margins <GO> |
| Revenue Growth (YoY) | 20.00% | 32.90% | -12.90 | GH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.52 | 5.44 | -2.92 | GH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.2 | 54.9 | -1.70 | GH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.94 | 0.87 | +0.07 | CNC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 19.0x | +17.00 | GH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $33.89B | $23.99B | $9.89B | CNC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNC REV | GH REV | CNC GROSS % | GH GROSS % | CNC FCF | GH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $174.58B | $982.0M | 8.1% | 64.5% | $4.32B | -$233.1M |
| FY 2024 | $145.50B | $739.0M | 11.7% | 60.8% | -$490.0M | -$274.9M |
| FY 2023 | $140.09B | $563.9M | — | — | $1.75B | -$350.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNC // BETA 0.94
GH // BETA 0.87